Vishal Manchanda, Pharma Analyst, Systematix Group, said potential US tariffs on pharmaceuticals are unlikely to have a broad impact on Indian drug makers, as...
Lupin Ltd. has received tentative approval from the US Food and Drug Administration (USFDA) for its Sugammadex Injection, according to an exchange filing on...
Deutsche Bank backs AtaiBeckley in the Psychedelic Renaissance, citing drugs BPL-003, VLS-01 and EMP-01 and projecting multibillion dollar sales after FDA approval.Deutsche Bank believes...